Total Payments
$11,133
2024 Payments
$56.89
Companies
34
Transactions
135
Medicare Patients
9,234
Medicare Billing
$1.1M
Payment Breakdown by Category
Research$8,690 (78.1%)
Food & Beverage$2,386 (21.4%)
Education$56.42 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $8,690 | 2 | 78.1% |
| Food and Beverage | $2,386 | 131 | 21.4% |
| Education | $56.42 | 2 | 0.5% |
Payments by Type
Research
$8,690
2 transactions
General
$2,442
133 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $8,690 | 2 | $0 (2020) |
| Boston Scientific Corporation | $382.95 | 24 | $0 (2023) |
| Medtronic Vascular, Inc. | $299.85 | 21 | $0 (2020) |
| Medtronic, Inc. | $217.39 | 10 | $0 (2024) |
| Abbott Laboratories | $215.58 | 10 | $0 (2019) |
| Gilead Sciences, Inc. | $184.02 | 7 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $140.32 | 8 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $108.03 | 8 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $101.09 | 6 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $92.94 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56.89 | 2 | Medtronic, Inc. ($56.89) |
| 2023 | $141.80 | 6 | Boston Scientific Corporation ($45.96) |
| 2022 | $235.35 | 12 | Novartis Pharmaceuticals Corporation ($78.33) |
| 2021 | $230.43 | 11 | Medtronic, Inc. ($105.54) |
| 2020 | $4,218 | 12 | Eli Lilly and Company ($4,043) |
| 2019 | $5,116 | 30 | Eli Lilly and Company ($4,647) |
| 2018 | $331.91 | 19 | Abbott Laboratories ($65.91) |
| 2017 | $802.26 | 43 | Gilead Sciences Inc ($150.70) |
All Payment Transactions
135 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $34.51 | General |
| Category: Pacemakers | ||||||
| 10/17/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Pacemakers | ||||||
| 09/12/2023 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $43.76 | General |
| 08/09/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Cardiology | ||||||
| 07/11/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: WATCHMAN_IC | ||||||
| 06/19/2023 | Boston Scientific Corporation | ACCOLADE SR (Device) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: ACCOLADE_CRM | ||||||
| 05/23/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $34.07 | General |
| Category: Cardiovascular Device | ||||||
| 02/11/2023 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: LUX-Dx_CRM | ||||||
| 11/23/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/21/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/17/2022 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: Cardiovascular | ||||||
| 07/07/2022 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Stents | ||||||
| 06/24/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/04/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/31/2022 | Bayer HealthCare Pharmaceuticals Inc. | Verquvo (Drug), Adempas | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Cardio-pulmonary | ||||||
| 03/17/2022 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: LUX-Dx_CRM | ||||||
| 03/14/2022 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Stents | ||||||
| 02/04/2022 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: LUX-Dx_CRM | ||||||
| 02/01/2022 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Stents | ||||||
| 01/20/2022 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: THERAPIES | ||||||
| 12/16/2021 | BOSTON SCIENTIFIC CORPORATION | LUX DX (Device) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/23/2021 | Medtronic, Inc. | VenaSeal (Device) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: EndoVenous Therapies | ||||||
| 11/10/2021 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | In-kind items and services | $48.74 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/06/2021 | Medtronic, Inc. | Resolute (Device) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Stents | ||||||
| 08/20/2021 | Bayer HealthCare Pharmaceuticals Inc. | Verquvo (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Cardio-pulmonary | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A STUDY OF TIRZEPATIDE (LY3298176) ONCE A WEEK VERSUS INSULIN GLARGINE ONCE A DAY IN PARTICIPANTS WITH TYPE 2 DIABETES AND INCREASED CARDIOVASCULAR RISK | Eli Lilly and Company | $8,690 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,112 | 3,264 | $829,296 | $243,900 |
| 2022 | 30 | 2,286 | 3,567 | $934,755 | $281,779 |
| 2021 | 33 | 2,349 | 3,649 | $901,006 | $285,192 |
| 2020 | 35 | 2,487 | 3,825 | $919,998 | $273,710 |
Total Patients
9,234
Total Services
14,305
Medicare Billing
$1.1M
Procedure Codes
134
All Medicare Procedures & Services
134 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 594 | 916 | $160,300 | $78,578 | 49.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 269 | 277 | $202,275 | $37,171 | 18.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 89 | 174 | $138,600 | $28,890 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 158 | 171 | $21,375 | $10,592 | 49.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 59 | 236 | $16,520 | $10,278 | 62.2% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 27 | 27 | $32,400 | $10,082 | 31.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 88 | 176 | $26,400 | $8,525 | 32.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 57 | 57 | $21,375 | $7,404 | 34.6% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 12 | 12 | $12,000 | $7,042 | 58.7% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 30 | 31 | $34,100 | $5,554 | 16.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 67 | 80 | $11,116 | $4,451 | 40.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 74 | 187 | $14,960 | $4,052 | 27.1% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 14 | 14 | $16,800 | $3,717 | 22.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 74 | 75 | $20,625 | $3,692 | 17.9% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 86 | 218 | $16,350 | $3,355 | 20.5% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 15 | 83 | $6,225 | $3,305 | 53.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 70 | 70 | $17,500 | $3,230 | 18.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 15 | $3,750 | $1,975 | 52.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,125 | $1,764 | 42.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 17 | $3,060 | $1,731 | 56.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $3,120 | $1,616 | 51.8% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 15 | 77 | $5,005 | $1,440 | 28.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 89 | 134 | $8,710 | $1,358 | 15.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 80 | 83 | $16,600 | $802.53 | 4.8% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 14 | 31 | $4,650 | $772.74 | 16.6% |
About Dr. Daniel Humiston, MD
Dr. Daniel Humiston, MD is a Cardiovascular Disease healthcare provider based in Farmington, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780679829.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Humiston, MD has received a total of $11,133 in payments from pharmaceutical and medical device companies, with $56.89 received in 2024. These payments were reported across 135 transactions from 34 companies. The most common payment nature is "" ($8,690).
As a Medicare-enrolled provider, Humiston has provided services to 9,234 Medicare beneficiaries, totaling 14,305 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 134 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Farmington, UT
- Active Since 09/14/2005
- Last Updated 06/13/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1780679829
Products in Payments
- Resolute (Device) $346.66
- CardioMEMS HF System (Device) $174.62
- ENTRESTO (Drug) $124.67
- XARELTO (Drug) $101.09
- ELIQUIS (Drug) $76.98
- WATCHMAN (Device) $76.58
- Repatha (Biological) $69.51
- LUX-Dx Insertable Cardiac Monitor (Device) $69.19
- PRALUENT ALIROCUMAB INJECTION (Biological) $67.68
- UPTRAVI (Drug) $64.04
- MICRA (Device) $56.89
- RESOLUTE ONYX (Device) $54.96
- Barostim Neo System (Device) $48.74
- SQ-RX PULSE GENERATOR (Device) $46.71
- VenaSeal (Device) $45.77
- OPSUMIT (Drug) $43.99
- Vascepa (Drug) $34.24
- OPTIMIZER (Device) $34.07
- EMBLEM S-ICD (Device) $33.26
- Verquvo (Drug) $30.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Farmington
Michael West, Md, MD
Cardiovascular Disease — Payments: $105,217
Cardiovascular Disease $105,217
Dr. Khagendra Dahal, Md, MD
Cardiovascular Disease — Payments: $41,421
Cardiovascular Disease $41,421
Dr. Azamuddin Khaja, M.d, M.D
Cardiovascular Disease — Payments: $24,998
Cardiovascular Disease $24,998
Juyong Lee, Md/Phd, MD/PHD
Cardiovascular Disease — Payments: $17,527
Cardiovascular Disease $17,527
Bhavananda Reddy, Md, MD
Cardiovascular Disease — Payments: $16,555
Cardiovascular Disease $16,555
Shubhi Pandey
Cardiovascular Disease — Payments: $14,499
Cardiovascular Disease $14,499